The RD1 Product

The RD1, which is based on RedDress’ proprietary patented technology, is the first wound care product which enables health care providers to produce in real time, in vitro whole blood clots, for use as a chronic wound care product. The RD1 has been developed to address the need for cost effectiveness and clinical effectiveness of wound care.

The RD1 preparation process takes 12 minutes and the RD1 Clot is then applied to the wound.